Form 8-K - Current report:
SEC Accession No. 0001193125-25-182222
Filing Date
2025-08-18
Accepted
2025-08-18 08:00:37
Documents
12
Period of Report
2025-08-13
Items
Item 1.02: Termination of a Material Definitive Agreement

Document Format Files

Seq Description Document Type Size
1 8-K d59058d8k.htm   iXBRL 8-K 23394
  Complete submission text file 0001193125-25-182222.txt   133537

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA adpt-20250813.xsd EX-101.SCH 2872
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE adpt-20250813_lab.xml EX-101.LAB 17233
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE adpt-20250813_pre.xml EX-101.PRE 10826
15 EXTRACTED XBRL INSTANCE DOCUMENT d59058d8k_htm.xml XML 3549
Mailing Address 1165 EASTLAKE AVE E SEATTLE WA 98109
Business Address 1165 EASTLAKE AVE E SEATTLE WA 98109 206-659-0067
Adaptive Biotechnologies Corp (Filer) CIK: 0001478320 (see all company filings)

EIN.: 270907024 | State of Incorp.: WA | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38957 | Film No.: 251226309
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)